Genvor Inc
GNVR· OTC
Filed Feb 12, 2026 · 10-Q · 43 days after period end · 0001903596-26-000040
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$576.28K | -$5.00M | -$1.35M | -$179.62K |
| EPS Diluted | -$0.02 | -$0.24 | -$0.07 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Genvor Inc · CIK 1792941 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Feb 12, 2026 · 43 d after period end